Bond Screener
Amneal Pharmaceuticals
LEI 549300VV176ZO5WQHZ61
Organization name
Amneal Pharmaceuticals, Inc.
Country name
USA
Country of registration
USA
Industry
Pharmaceutical Preparation and Biotechnology
Credit Ratings
in foreign currency
Public debt
600 mln USD
New to Cbonds? · Take a 90-second tour of the platform.
Discover what you can do with Cbonds
Everything you need for fixed income research and monitoring.
- 00:23 Coverage
- 00:40 Bond screener
- 00:54 Parameters
- 01:10 Watchlist, Mobile app
- 01:15 Excel Add-in
Trading Schedule Issuer map
Quotes
/
/
/
pcs.
pcs.
pcs.
- «
- 1
- ...
- {{ quotes.page - 2 }}
- {{ quotes.page - 1 }}
- {{ quotes.page }}
- {{ quotes.page + 1 }}
- {{ quotes.page + 2 }}
- ...
- {{ quotesLastPage }}
- »
Quotes provided by information providers are indicative in nature
Profile
|
Amneal Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and distributes generic pharmaceutical products for various dosage forms and therapeutic areas.
|
General information
-
Organization nameAmneal Pharmaceuticals, Inc.
-
Organization statusOperating organization
-
Address3rd Floor, Bridgewater, USA, 08807
-
Site
News
-
Amneal Pharmaceuticals: Entry Into A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant, Unregistered Sales Of Equity Securities, Regulation Fd Disclosure, Financial Statements And Exhibits10/08/2026
-
Amneal Pharmaceuticals: Results Of Operations And Financial Condition, Financial Statements And Exhibits07/05/2026
-
Amneal (AMRX) Reports Strong Q1, Raises 2026 EPS Guidance01/05/2026
-
Amneal Pharmaceuticals: Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Unregistered Sales Of Equity Securities, Regulation Fd Disclosure, Financial Statements And Exhibits22/04/2026
-
Amneal Pharmaceuticals: Entry Into A Material Definitive Agreement, Creation Of A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement Of A Registrant02/02/2026
IFRS/US GAAP reports
| 2026 | |
| 2025 | |
| 2024 | |
| 2023 | |
| 2022 | |
| 2021 | |
| 2020 | |
| 2019 | |
| 2018 | |
| 2017 | |
Show more
Hide
Authorization required
You need to request access
Stocks
General information
-
Organization nameAmneal Pharmaceuticals, Inc.
-
Organization statusOperating organization
-
Address3rd Floor, Bridgewater, USA, 08807
-
Site
Codes
-
LEI549300VV176ZO5WQHZ61
-
SIC2834 PHARMACEUTICAL PREPARATIONS
-
NACE*** ***
-
NAICS*** ***
-
CIK0001723128
